Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1544 publications

Functional Evaluation of TRPC6 Missense Variants in Cancer Patients via Molecular Docking Analysis Compared with Patch Clamp Electrophysiology.

Functional Evaluation of TRPC6 Missense Variants in Cancer Patients via Molecular Docking Analysis Compared with Patch Clamp Electrophysiology.

Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026

Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies MMP16 and KCTD15 as risk loci.

Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies MMP16 and KCTD15 as risk loci.

Journal: medRxiv : the preprint server for health sciences
Published: December 25, 2025

In Vivo Immunomodulatory Programming of Circulating Myeloid Cells via Itaconic Acid Liposomes to Mitigate Myocarditis.

In Vivo Immunomodulatory Programming of Circulating Myeloid Cells via Itaconic Acid Liposomes to Mitigate Myocarditis.

Journal: ACS nano
Published: December 17, 2025

Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications.

Role of FGF21 in Heart Failure: Molecular Insights and Therapeutic Implications.

Journal: Cardiology in review
Published: November 06, 2025

Chemotherapy-Induced Cardiomyopathy in Pregnancy: A Multidisciplinary Approach.

Chemotherapy-Induced Cardiomyopathy in Pregnancy: A Multidisciplinary Approach.

Journal: JACC. Case reports
Published: October 30, 2025

Persistently increased CaMKIIδ autophosphorylation mediates pathologic SR Ca loss in a murine model of Doxorubicin-induced cardiomyopathy.

Persistently increased CaMKIIδ autophosphorylation mediates pathologic SR Ca loss in a murine model of Doxorubicin-induced cardiomyopathy.

Journal: Journal of molecular and cellular cardiology plus
Published: October 30, 2025

Chemotherapy-Induced Cardiotoxicity in Breast Cancer: Mechanisms, Diagnostic Advances, and Emerging Protective Strategies.

Chemotherapy-Induced Cardiotoxicity in Breast Cancer: Mechanisms, Diagnostic Advances, and Emerging Protective Strategies.

Journal: American journal of physiology. Heart and circulatory physiology
Published: October 16, 2025

Reprogramming of the kynurenine pathway impairs NAD+ homeostasis and mediates doxorubicin-induced cardiotoxicity in mice.

Reprogramming of the kynurenine pathway impairs NAD+ homeostasis and mediates doxorubicin-induced cardiotoxicity in mice.

Journal: Redox biology
Published: October 06, 2025

A Successful Spontaneous Delivery Case after Cardioprotective Drug Discontinuation for Severe Doxorubicin-Induced Cardiomyopathy.

A Successful Spontaneous Delivery Case after Cardioprotective Drug Discontinuation for Severe Doxorubicin-Induced Cardiomyopathy.

Journal: International heart journal
Published: October 01, 2025

DHDK, a Plant-Derived Natural Small Molecule, Protects Against Doxorubicin-Induced Cardiotoxicity via the PPARG-CPT1B-FAO Axis.

DHDK, a Plant-Derived Natural Small Molecule, Protects Against Doxorubicin-Induced Cardiotoxicity via the PPARG-CPT1B-FAO Axis.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 29, 2025

Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline-induced cardiomyopathy in elderly patients with Hodgkin lymphoma.

Liposomal doxorubicin in place of doxorubicin hydrochloride to prevent anthracycline-induced cardiomyopathy in elderly patients with Hodgkin lymphoma.

Journal: HemaSphere
Published: September 25, 2025

Role of myocardium-derived exosomal miRNAs in doxorubicin-induced cardiomyopathy.

Role of myocardium-derived exosomal miRNAs in doxorubicin-induced cardiomyopathy.

Journal: Gene
Published: September 15, 2025
Showing 1-12 of 1,544

Last Updated: 02/24/2026